September 2021 - Page 6 of 35

TuesdaySep 28, 2021 9:00 am

InnerScope Hearing Technologies Inc. (INND) Showcases Unmatched Hearing Technology During Home Health and Diabetes Care Program

Home Health and Diabetes Care Program helps suppliers present their offerings to buyers from major US chains actively searching for new products to sell InnerScope raised buyers' interest as the only company presenting direct-to-consumer hearing products; scheduled 50 one-on-one meetings with corporate buyers from major US retailers Company is poised to forge key strategic relationships to build robust distribution network with industry-leading partners InnerScope Hearing Technologies (OTC: INND), an emerging disruptive leader in the direct-to-consumer hearing technology space, participates in the virtual Home Health & Diabetes Care Program — an event that connects sellers and corporate buyers (https://ibn.fm/XCtPR). With its…

MondaySep 27, 2021 2:37 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Announces Launch of the ‘Desire Project’

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research in psychedelics, today unveiled its “Desire Project,” a clinical research program focused on the treatment of female hypoactive sexual desire disorder with MDMA-assisted psychotherapy. According to the update, the research program will mark the first psychedelic-based treatment program targeted at addressing what is clinically known as Hypoactive Sexual Desire Disorder (“HSDD”), a common sexual disorder characterized by persistent low sexual desire and emotional distress not attributable to an existing medical condition or relationship issue. Current estimates indicate that HSDD affects 10% of…

MondaySep 27, 2021 2:09 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Automotive Inc. Release Update Letter to Shareholders

Mullen Automotive, an emerging electric vehicle manufacturer, which previously announced a definitive stock-for-stock reverse merger agreement with Net Element (NASDAQ: NETE), in which Mullen’s stockholders will receive a majority of the outstanding stock in the post-merger company, today released a letter to shareholders from Mullen’s CEO David Michery. “As we begin the fourth quarter of 2021, I would like to take this opportunity to update everyone on the progress being made to complete the merger with Net Element. I am pleased to say that the SEC has declared effective the S-4 registration statement of the shares of the merger. The shareholders…

MondaySep 27, 2021 1:45 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Launches Keef Beverages in Ontario Through the OCS

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, today announced the shipment of its award-winning Keef Brands cannabis-infused beverages to the Ontario Cannabis Store (“OCS”). According to the update, the Keef products will be available in Ontario retail locations across the province and online at OCS.ca in October 2021. The products are also expected to hit British Columbia and Alberta shelves by early November 2021. “We’re very excited to launch these top-selling and highly anticipated beverages in Ontario through the OCS,” said BevCanna’s President Melise Panetta. “The OCS is the largest…

MondaySep 27, 2021 1:41 pm

StorEn Technologies Inc. Announces ANYSeed Converts Note, Becomes New Shareholder

StorEn issued ANYSeed a convertible note in 2019; the fund recently converted the note into equity ANYSeed supports science and technology-based, early-stage ventures located in downstate New York Focused on offering innovative battery storage, StorEn Technologies is leading way in the development of evolutionary vanadium flow batteries StorEn Technologies, a developer of evolutionary vanadium flow batteries with a disruptive patent-pending, all-vanadium flow battery technology, has announced that Accelerate New York Seed Fund (ANYSeed) has become a shareholder (https://ibn.fm/vJewK). “Over three years ago, in March of 2019, we raised funds from ANYSeed and issued them a convertible note after receiving the…

MondaySep 27, 2021 1:24 pm

QualityStocksNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX), Subsidiaries Slated to Present Solutions During Upcoming Sustainable Fleet Technology Conference

Ideanomics (NASDAQ: IDEX), a global company focused on driving the adoption of commercial electric vehicles and associated energy consumption, will be participating in the monthlong, all-virtual Sustainable Fleet Technology (“SFT”) Conference. The conference is designed to showcase the “latest and greatest” in sustainable fleet tech, operations and implementations. The conference takes place twice a week — Tuesday and Thursdays — from 2–3:30 p.m. EST, and runs through Oct. 19, 2021. Ideanomics, along with its subsidiaries WAVE and US Hybrid, will be participating in panel discussions scheduled for Sept. 30, Oct. 12 and Oct. 14. IDEX chief scientist and US Hybrid CEO…

MondaySep 27, 2021 1:19 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Reveals Attendance at This Year’s H.C. Wainwright Global Investment Conference

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently revealed its participation at the annual H.C. Wainwright Global Investment Conference, held between September 13-15, 2021 Through its sugarBEAT flagship product, Nemaura has sought to capitalize on the expanding Type 2 Diabetes market, expected to reach an annual value of $59 billion by 2025 Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs; the company’s flagship product, the sugarBEAT(R), is a wearable, non-invasive and flexible Continuous Glucose Monitor designed…

MondaySep 27, 2021 1:07 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Eyes Commercial Plans to Become B2B Wholesale Supplier of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company based in British Columbia, Canada, is focused on advancing a pipeline of cannabinoid-based pharmaceutical drug candidates. The company is developing a proprietary cannabinoid synthesis manufacturing system known as IntegraSyn(TM), which is designed to advance rare and lesser-known cannabinoid production to commercial levels. A recent article discussing this quotes InMed CEO Eric A. Adams. “The next key milestone is to manufacture our first large-scale batch through a pharma-grade-ready process in the coming months. We will continue to optimize the process and scale up the IntegraSyn process into larger vessels,” Adams said in a recent…

MondaySep 27, 2021 12:52 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes First Step in European Expansion Plan

Flora Growth Corp. (NASDAQ: FLGC) recently closed a €2 million investment in Hoshi International Inc., a fully integrated cannabis company, and uniquely positioned to become the leading provider of cannabis and derivative products for the budding European market. With the investment, Flora is set to capitalize on Hoshi’s strong European presence as well as leverage its technical know-how and understanding of its European market to not only expand its reach but also obtain its European Union Good Manufacturing Practices (“EU-GMP”) certification. A recent article reads, “Flora hopes to capitalize on Hoshi’s understanding of and presence within the European market to…

MondaySep 27, 2021 12:34 pm

QualityStocksNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Strategic Commercial Agreement with UK Licensee

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced its entry into a global commercial contract with MySugarWatch DuoPack Limited (“MSW-DP”). Under the agreement, the continuous glucose monitor (“CGM”) and sensors will be provided as duo packs with prescription only medicines that are widely prescribed for people with type 2 diabetes. MSW-DP has been granted global rights to the sugarBEAT(R) non-invasive CGM devices and sensors, to be provided solely as duo packs with these medicines, under the terms of the agreement, which Nemaura will…

Site Search

Company Search

Month: September 2021